Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.80 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | CES1 | P23141 | 4/20 | 0.50 |
| ▸ | CES2 | O00748 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | MMP1 | P03956 | 2/20 | 0.42 |
| ▸ | MMP2 | P08253 | 2/20 | 0.42 |
| ▸ | MMP3 | P08254 | 2/20 | 0.42 |
| ▸ | MMP8 | P22894 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2479243 | 0.92 | LMNA (0.76) | LMNAALDH1A1CES1CES2TSHR | |
| SCHEMBL782025 | 0.90 | LMNA (0.73) | LMNAALDH1A1CES1CES2TSHR | |
| SCHEMBL6117074 | 0.90 | LMNA (0.73) | LMNAALDH1A1CES1CES2TSHR | |
| SCHEMBL781111 | 0.90 | LMNA (0.73) | LMNAALDH1A1CES1CES2TSHR | |
| SCHEMBL782148 | 0.90 | LMNA (0.73) | LMNAALDH1A1CES1CES2TSHR | |
| SCHEMBL23646903 | 0.90 | LMNA (0.73) | LMNAALDH1A1CES1CES2TSHR | |
| SCHEMBL780994 | 0.90 | LMNA (0.73) | LMNAALDH1A1CES1CES2TSHR | |
| N,N-Diethylstearamide SCHEMBL738376 | 0.90 | LMNA (0.73) | LMNAALDH1A1CES1CES2TSHR | |
| SCHEMBL79816 | 0.90 | LMNA (0.73) | LMNAALDH1A1CES1CES2TSHR | |
| Dodecane SCHEMBL9716087 | 0.90 | LMNA (0.73) | LMNAALDH1A1CES1CES2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024058169-A1 | WEAK-ANCHORING LIQUID CRYSTAL ALIGNING AGENT AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2024-03-21 | — | — | WO | claimed |
| WO-2024058164-A1 | LIQUID CRYSTAL ALIGNING AGENT AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2024-03-21 | — | — | WO | claimed |
| CN-113677660-A | Acetylsalicylic acid derivative and application thereof | 张婧 | 2021-11-19 | — | — | CN | claimed |
| EP-3430057-A1 | USE OF APE1/REF-1 INHIBITORS IN COMBINATION THERAPIES FOR TREATMENT OF CANCER | Indiana University Research & Technology Corporation (US) | 2019-01-23 | — | — | EP | claimed |
| WO-2018175429-A1 | USE OF APE1/REF-1 INHIBITORS IN COMBINATION THERAPIES FOR TREATMENT OF CANCER | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2018-09-27 | — | — | WO | claimed |
| US-12630731-B2 | Non-aqueous ink composition | DNP FINE CHEMICALS CO., LTD. (JP) | 2026-05-19 | — | — | US | disclosed |
| US-20260125570-A1 | NONAQUEOUS INK COMPOSITION, RECORDING METHOD, METHOD FOR PRODUCING RECORDED MATERIAL, INK SET, RECORDED MATERIAL, AND INKJET RECORDING APPARATUS | DNP FINE CHEMICALS CO., LTD. (JP) | 2026-05-07 | — | — | US | disclosed |
| US-12590216-B2 | Water-based ink and ink set including same | DNP FINE CHEMICALS CO., LTD. (JP) | 2026-03-31 | — | — | US | disclosed |
| US-12522744-B2 | Ink set | DNP FINE CHEMICALS CO., LTD. (JP) | 2026-01-13 | — | — | US | disclosed |
| US-20250368766-A1 | RESIN, RESIN DISPERSION, AND RESIN COMPOSITION | DNP FINE CHEMICALS CO., LTD. (JP) | 2025-12-04 | — | — | US | disclosed |
| EP-4617333-A1 | NONAQUEOUS INK COMPOSITION, RECORDING METHOD, METHOD FOR PRODUCING RECORDED MATERIAL, INK SET, RECORDED MATERIAL, AND INKJET RECORDING APPARATUS | DNP Fine Chemicals Co., Ltd. (JP) | 2025-09-17 | — | — | EP | disclosed |
| US-12398444-B2 | Diglycolamide derivatives for separation and recovery of rare earth elements from aqueous solutions | UT-BATTELLE, LLC (US) | 2025-08-26 | — | — | US | disclosed |
| US-20080139559-A1 | DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS | IRM LLC, A DELAWARE LIMITED LIABILITY COMAPNY (BM) | 2008-06-12 | — | — | US | disclosed |
| US-20080139597-A1 | DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS | IRM LLC, A DELAWARE LIMITED LIABILITY COMAPNY (BM) | 2008-06-12 | — | — | US | disclosed |
| US-20070149538-A1 | Diarylamine-Containing Compounds and Compositions, and their use as Modulators of C-Kit Receptors | IRM LLC (BM) | 2007-06-28 | — | — | US | disclosed |
| US-20070043023-A1 | Modulators of muscarinic receptors | VERTEX PHARMACEUTICALS INCORPORATED | 2007-02-22 | — | — | US | disclosed |
| CN-1468214-A | Novel derivatives of aminocyclohexane | - | 2004-01-14 | — | — | CN | disclosed |
| US-5224987-A | Aqueous carriers with colors and tertiary amide penetrants | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-07-06 | — | — | US | disclosed |
| US-4490263-A | WITH SODIUM CHLORIDE, AND SULFONATE | PHILLIPS PETROLEUM COMPANY (US) | 1984-12-25 | — | — | US | disclosed |
| US-4377533-A | PROPYLATION OF NITRILES | SANOFI (FR) | 1983-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630731-B2 | Non-aqueous ink composition | EXOSC10, RPP30, RPS20 | LMNA 3836/4885ALDH1A1 1893/4885CES1 4736/4885 |
| US-20080139597-A1 | DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS | KIT, PRKCH, PRKCE | LMNA 710/4885ALDH1A1 1472/4885CES1 1978/4885 |
| US-12590216-B2 | Water-based ink and ink set including same | TYR, ITGB3, ARCN1 | LMNA 2340/4885ALDH1A1 1130/4885CES1 4598/4885 |
| US-12398444-B2 | Diglycolamide derivatives for separation and recovery of rare earth elements from aqueous solutions | GNE, GALE, ARGLU1 | LMNA 3366/4885ALDH1A1 3536/4885CES1 313/4885 |
| US-20070149538-A1 | Diarylamine-Containing Compounds and Compositions, and their use as Modulators of C-Kit Receptors | KIT, PRKCH, PRKCE | LMNA 710/4885ALDH1A1 1472/4885CES1 1978/4885 |
| US-20080139559-A1 | DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS | KIT, PRKCH, PRKCE | LMNA 710/4885ALDH1A1 1472/4885CES1 1978/4885 |
| US-20070043023-A1 | Modulators of muscarinic receptors | CHRM3, CHRM5, CHRM2 | LMNA 4093/4885ALDH1A1 2356/4885CES1 917/4885 |
| US-20260125570-A1 | NONAQUEOUS INK COMPOSITION, RECORDING METHOD, METHOD FOR PRODUCING RECORDED MATERIAL, INK SET, RECORDED MATERIAL, AND INKJET RECORDING APPARATUS | BMI1, IK, PRDM9 | LMNA 3395/4885ALDH1A1 333/4885CES1 4436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.